Search

everythinglearnresearchcommunity

for

Search:↓

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The human microbiome is vital for health and can help treat diseases.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

ILC1 cells contribute to hair loss in alopecia areata.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Gentamicin penetrates pig skin better through open hair follicles than blocked ones.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

PCOS symptoms vary by age, affecting diagnosis and treatment.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Fullerenes are safe and useful antioxidants in cosmetics.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Tofu whey improves foot skin health and supports sustainable cosmetics.

Impaired skin barrier function worsens acne.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The document explains how hair follicles develop, their structure, and how they grow.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.